Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323722 | SCV000919202 | pathogenic | Cystic fibrosis | 2023-07-10 | criteria provided, single submitter | clinical testing | Variant summary: CFTR c.2573delG (p.Ser858ThrfsX2) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, a commonly known mechanism for disease. The variant was absent in 251324 control chromosomes (gnomAD). To our knowledge, no occurrence of c.2573delG in individuals affected with Cystic Fibrosis and no experimental evidence demonstrating its impact on protein function have been reported. One submitter has provided a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Baylor Genetics | RCV003472317 | SCV004213348 | likely pathogenic | Bronchiectasis with or without elevated sweat chloride 1 | 2023-09-30 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001825531 | SCV002080775 | likely pathogenic | CFTR-related disorder | 2017-03-16 | no assertion criteria provided | clinical testing |